Godrej Consumer Q4 FY26: Profit up 10%, shares drop

Stock slides despite earnings growth

Shares of Godrej Consumer Products (GCPL) fell sharply in trade on Thursday even after the company reported higher March-quarter earnings. The stock slipped 5.5% to an intraday low of Rs 1,035 on the BSE. It later pared losses but remained in the red, with one update noting it ended down 0.70% at Rs 1,094.60, while another report put the close near Rs 1,095, down 0.67%.

The market reaction came alongside a results print that showed steady growth in revenue, profit and operating earnings, supported by volume expansion in India and gains in several international markets. Investors also tracked commentary on input-cost pressure and the pace of pricing-led growth in the next few quarters.

Q4 FY26 profit rises to about Rs 452 crore

GCPL reported a 9.67%-9.7% year-on-year rise in consolidated net profit for Q4 FY26 to about Rs 451.77-452 crore. Profit before tax (PBT) rose 1.89% YoY to Rs 651.47 crore for the quarter ended March 31, 2026.

Revenue for the quarter increased to around Rs 3,884.90-3,900 crore, with updates citing 11% growth versus Rs 3,514 crore a year earlier and a filing showing sales up 1.18% to Rs 3,884.90 crore. The company also reported that revenue grew 7% YoY in constant currency terms.

EBITDA grows; margin steady near 21.6%-21.7%

Operating performance was stable, with EBITDA reported at Rs 841.4 crore versus Rs 759.2 crore a year earlier, an increase of about 11%. Another update described EBITDA growth of about 10% YoY. EBITDA margin was broadly flat at 21.6%, with a separate filing noting 21.7%.

The company attributed the quarter’s consolidated sales growth to underlying volume growth of 6%. This volume-led expansion, alongside cost management, helped maintain margins despite a competitive and inflation-sensitive operating environment.

India business leads volumes; standalone margin stronger

GCPL’s standalone business posted 8% volume growth in Q4 FY26, with sales rising 10%. Management said the standalone India business delivered an “excellent quarter,” driven by 8% underlying volume growth and 10% sales growth.

The company also highlighted a stronger profitability profile in the standalone business for the quarter, with standalone EBITDA up 18% and margin at 24.7%. Management linked this to disciplined cost management, calibrated pricing actions and improved operating leverage.

International markets: mixed Indonesia, strong Africa-US-West Asia

International performance varied by geography. Indonesia sales increased 3% in Q4 FY26, while Africa, the US and West Asia delivered 20% growth. Management said pricing pressures in Indonesia that had persisted over several quarters had “largely bottomed out,” and it is seeing early signs of stabilisation.

For Indonesia specifically, management cited 4% underlying volume growth alongside 3% sales growth in the quarter. It added that operating conditions are expected to improve from FY2027 as the market normalises.

Full-year FY26: sales up, profit largely flat

For FY26, consolidated sales rose 9% year-on-year, driven by 6% volume growth. On the standalone side, sales grew 8% with volume growth of 6%.

On a full-year basis, the company reported consolidated net profit up 0.50% to Rs 1,861.47 crore. Revenue from operations for FY26 increased 8.5% to Rs 15,100 crore.

Dividend update for FY27

In a separate filing, GCPL said its board declared an interim dividend of 500%, which is Rs 5 per share on a face value of Re 1 each, for 2026-27. The dividend announcement came alongside the quarterly results.

Broker views: targets at Rs 1,159 and Rs 1,300

Morgan Stanley maintained an Equal-weight rating on GCPL with a target price of Rs 1,159, implying an upside of about 6% from current levels cited in the report. The brokerage expects stronger pricing-led topline growth in Q1 and Q2 FY27, while noting that margins could remain under pressure.

Motilal Oswal maintained a ‘Buy’ rating with a target price of Rs 1,300, implying a potential upside of 19%.

Pricing actions and margin guidance for FY27

Morgan Stanley noted that the company implemented price hikes across soaps, detergents and home insecticides in April. It also flagged that the India business reported 8% volume growth and EBITDA margin remained within the guided range.

Management has guided for FY27 EBITDA margins in the 24-26% band. Separately, a company update referenced commodity cost pressures, citing Brent crude at $100-110 and palm oil at 4,500-4,800 MYR, translating into a 6-9% cost impact.

Key numbers at a glance

What the market is weighing

The sharp intraday fall, despite higher earnings, suggests investors were focused on the near-term balance between pricing actions and input-cost pressure. Broker commentary also pointed to potential margin pressure even as pricing-led growth improves in the early part of FY27.

At the same time, GCPL’s reported volume growth in India and a stronger standalone EBITDA margin in Q4 FY26 stand out, along with stronger growth in Africa, the US and West Asia. The market’s next cues are likely to come from the trajectory of commodity costs, the impact of April price hikes, and how closely consolidated margins track management’s FY27 margin guidance.

Conclusion

GCPL reported higher Q4 FY26 profit and double-digit growth in revenue and EBITDA, supported by 6% underlying volume growth and a strong quarter in the standalone India business. The stock, however, fell to an intraday low of Rs 1,035 as investors assessed margin headwinds, commodity cost pressure and the pace of pricing-led growth, while tracking targets of Rs 1,159 (Morgan Stanley) and Rs 1,300 (Motilal Oswal).